Nutritional Outlook welcomes Osvaldo Marinotti, PhD, senior biochemist for CV Sciences, to editorial advisory board
Marinotti has over 30 years of research experience as well as an extensive record of scientific publications and international collaborations.
Osvaldo Marinotti, PhD, senior biochemist for CV Sciences
Nutritional Outlook welcomes Osvaldo Marinotti, PhD, senior biochemist for CV Sciences (San Diego, CA), to its editorial advisory board (EAB). Marinotti earned his PhD in biochemistry from the University of Sao Paulo in Brazil, where he also earned his MSc in biochemistry and BSc in biology. He has over 30 years of research experience as well as an extensive record of scientific publications and international collaborations. In addition to his position at CV Sciences, Marinotti founded and leads research at MTEKPrime, a research consultancy specializing in biotechnology, genetic engineering, molecular biology, and biochemistry.
Prior to Marinotti, Duffy MacKay, ND, represented CV Sciences on the EAB as its senior vice president of scientific and regulatory affairs. MacKay will continue to be an EAB member, representing the Consumer Healthcare Products Association (CHPA; Washington, D.C.) as its senior vice president of dietary supplements.
For a full list of Nutritional Outlook’s Editorial Advisory Board members, click here.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
